Elanco Animal Health
ELAN
360 hedge funds and large institutions have $11.5B invested in Elanco Animal Health in 2020 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 128 increasing their positions, 116 reducing their positions, and 68 closing their positions.
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
35% more capital invested
Capital invested by funds: $8.52B → $11.5B (+$3.01B)
10% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 116
3% less funds holding
Funds holding: 371 → 360 (-11)
12% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 68
11.8% less ownership
Funds ownership: 99.44% → 87.65% (-12%)
70% less call options, than puts
Call options by funds: $21.3M | Put options by funds: $70.1M
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$476M |
| 2 |
SHCM
Sachem Head Capital Management
New York
|
+$88.7M |
| 3 |
N
Natixis
Paris,
France
|
+$75.2M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$62.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.5M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$124M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$95.4M |
| 3 |
BlackRock
New York
|
-$94.5M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$40.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$35M |
ELAN Hedge Fund Activity: Q3 2020 in Review
360 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2020, worth a combined $11.5B — up 35% from $8.52B a quarter earlier.
Sellers outnumbered buyers: 68 funds closed out of ELAN and 60 opened new positions — a net loss of 8 holders — while 116 trimmed existing stakes and 128 added.
The largest buyer was Nomura Holdings, adding an estimated $476M. The largest seller was T. Rowe Price Associates, cutting an estimated $124M.
- 360 institutional investors held Elanco Animal Health (ELAN) as of Q3 2020, down from 371 in Q2 2020.
- Funds reported $11.5B of Elanco Animal Health stock for Q3 2020, up 35% quarter-over-quarter.
- 60 funds opened new Elanco Animal Health positions in Q3 2020 and 68 closed out, a net change of -8 holders.
- The largest Elanco Animal Health buyer in Q3 2020 was Nomura Holdings, an estimated $476M added.
- The largest Elanco Animal Health seller in Q3 2020 was T. Rowe Price Associates, an estimated $124M sold.
Based on aggregated 13F filings for Q3 2020.